Results 201 to 210 of about 308,825 (338)
Response in Relation to Baseline Anxiety Levels in Major Depressive Disorder Treated with Bupropion Sustained Release or Sertraline [PDF]
A. John Rush
openalex +1 more source
An analytical study was carried out by secondary analysis of a database of a study performed between 2010 and 2015 at the Naval Medical Center of Peru (CEMENA). the analysis revealed that depressive symptoms, polypharmacy, slow gait speed, education, and marital status were significant contributors to anxiety in this population.
Gianella Grajeda‐León+7 more
wiley +1 more source
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6‐week double‐blind study† [PDF]
J.P. Lépine+6 more
openalex +1 more source
Early onset major depressive disorder [PDF]
William Fleisher, Laurence Y. Katz
openalex +1 more source
Pathogen‐derived extracellular vesicle detection: theoretical insights and advanced methodologies: This review explores the theoretical foundations and practical applications of pEV detection, emphasizing the challenges and innovative strategies involving novel aggregate materials and machine learning for enhanced diagnostic accuracy.
Lihan Lai+6 more
wiley +1 more source
Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine [PDF]
Hui‐Chen Lo+7 more
openalex +1 more source
This study, utilizing two large‐cohort datasets, employs interpretable neural networks. It demonstrates that incorporating brain morphology and functional and structural networks enhances predictive accuracy for general psychopathology and its dimensions.
Jing Xia, Nanguang Chen, Anqi Qiu
wiley +1 more source
MicroRNAs: A Novel Approach for Monitoring Treatment Response in Major Depressive Disorder? [PDF]
Cătană CS+3 more
europepmc +1 more source